Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
biopharma save search
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-19 (Just crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
| Email alert
Add to watchlist
companies biopharma platform
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
Published: 2024-04-19 (Crawled : 11:00) - prnewswire.com
YS | News | $0.855 -8.65% -7.59% 360K
|
n/a
| Email alert
Add to watchlist
first year biopharma for financial results
Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
IMMX | News | $2.21 -11.6% -11.11% 190K
|
|
| O: -3.6%
H: 0.0%
C: 0.0%
nxc-201 biopharma
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
YS | News | $0.855 -8.65% -7.59% 360K
|
n/a
|
| O: -7.45%
H: 0.0%
C: 0.0%
hepatitis vaccine license granted biopharma virus trial
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Immix Biopharma on Track to Dose NXC-201 Patients in United States
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
IMMX | News | $2.21 -11.6% -11.11% 190K
|
|
| O: -3.6%
H: 0.0%
C: 0.0%
nxc-201 biopharma
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ABVC | News | $1.05 2.94% -2.38% 430K
|
Wholesale Trade
|
| O: -1.96%
H: 0.0%
C: 0.0%
life biopharma acquired
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
companies biopharma platform
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -5.82%
H: 0.0%
C: 0.0%
first report update financial results
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
|
| O: 5.41%
H: 41.06%
C: 29.66%
bb-301 first positive biopharma for trial opmd study
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
|
| O: 5.41%
H: 41.06%
C: 29.66%
million biopharma
Biopharma Layoff Tracker 2024: Fujifilm, Genentech, Sanofi and More Cut Staff
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
RLYB | $1.67 -5.11% -4.76% 270K
|
|
| O: -4.44%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
VXRT | $0.8423 -2.75% -3.6% 880K
|
Health Technology
|
| O: -0.49%
H: 2.25%
C: -2.25%
TXMD | $1.89 4.55% 5.7K
|
Health Technology
|
| O: 2.63%
H: 3.59%
C: -3.08%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
PTCT | $24.69 -1.87% -1.82% 820K
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: -1.33%
NKTR | $1.32 -2.22% -3.85% 2.4M
|
Health Technology
|
| O: -0.67%
H: 1.35%
C: -8.78%
MOR | $18.05 0.06% -0.11% 590K
|
Health Technology
|
| O: 0.17%
H: 0.39%
C: 0.33%
GLPG | $28.91 -1.06% -1.11% 130K
|
Health Technology
|
| O: -0.14%
H: 0.17%
C: -0.78%
AMRN | $0.8718 -4.94% -4.23% 1M
|
Health Technology
|
| O: 3.69%
H: 0.0%
C: 0.0%
GOOGL | News S | $156.01 0.35% 0.32% 16M
|
Technology Services
|
| O: 1.03%
H: 0.94%
C: -0.1%
GOOG | News S | $157.46 0.37% 0.39% 12M
|
Technology Services
|
| O: 0.97%
H: 0.95%
C: -0.2%
OCX J | $2.56 -1.16% -2.78% 36K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: -5.47%
biopharma sanofi
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
companies biopharma platform
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ABVC | News | $1.05 2.94% -2.38% 430K
|
Wholesale Trade
|
| O: 2.68%
H: 3.48%
C: -11.3%
treatment biopharma royalties global for agreement
Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement
Published: 2024-04-17 (Crawled : 11:00) - prnewswire.com
VEEV | News | $199.54 0.17% -0.77% 720K
|
Technology Services
|
| O: 0.09%
H: 0.0%
C: 0.0%
biopharma commercial leaders
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
Published: 2024-04-17 (Crawled : 11:00) - globenewswire.com
FWBI | $2.84 -2.07% -2.84% 30K
|
Manufacturing
|
| O: -5.79%
H: 4.1%
C: -1.02%
first ceo biopharma microcap
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
business year update biopharma financial results
Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
PPCB | $0.001 -28.57% -41.86% 11M
|
Manufacturing
|
| O: 0.0%
H: 14.29%
C: -7.14%
patent cancer biopharma for grant
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
XOMA | News | $24.59 1.4% 2.84% 15K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -0.97%
biopharma platform
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
NURO | $3.65 2.24% 10.3% 3.9K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.